Abdel-Aal Ahmed Kamel, Elsabbagh Ahmed, Soliman Hesham, Hamed Maysoon, Underwood Edgar, Saddekni Souheil
Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA
Vasc Endovascular Surg. 2014 Oct-Nov;48(7-8):516-21. doi: 10.1177/1538574414561230. Epub 2014 Dec 8.
Although renal arteriovenous fistula (AVF) is an uncommon condition, it may lead to high cardiac output heart failure and renal insufficiency. Recently, percutaneous transcatheter embolization has replaced traditional surgery as the first line of treatment. We report a case of a 68-year-old male who presented with a renal AVF and was treated by percutaneous transcatheter embolization using the Amplatzer Vascular Plug 2 (AVP 2; St Jude Medical, Plymouth, Minnesota) through an arterial access. To our knowledge, the use of AVP 2 device in the treatment of renal AVF as a single embolotherapy device through the transarterial route has not been previously reported in the literature. Our technique demonstrates the feasibility and safety of AVP 2 device in the treatment of renal AVF.
虽然肾动静脉瘘(AVF)并不常见,但它可能导致高心输出量心力衰竭和肾功能不全。最近,经皮经导管栓塞术已取代传统手术成为一线治疗方法。我们报告一例68岁男性患者,其患有肾动静脉瘘,并通过经动脉途径使用Amplatzer血管封堵器2(AVP 2;圣犹达医疗公司,明尼苏达州普利茅斯)进行经皮经导管栓塞治疗。据我们所知,此前文献中尚未报道过将AVP 2装置作为单一栓塞治疗装置经动脉途径用于治疗肾动静脉瘘。我们的技术证明了AVP 2装置治疗肾动静脉瘘的可行性和安全性。